Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Michael R. Green, Man Chun John et al.|Cancer Discovery|2020Cited by 159
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphomaPatrizia Mondello, Anas Younes|Oncotarget|2017Cited by 67
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutationsPatrizia Mondello, Anas Younes|JCI Insight|2017Cited by 46
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W. Merryman, Heather A. Jacene, Laure Michaud et al.|HemaSphere|2023Cited by 11
Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line ChemoimmunotherapyReid W. Merryman, Heather A. Jacene, Gabriela Spilberg et al.|Blood|2020Cited by 1